肺鳞癌组织miRNA-193a及miRNA-4286水平与预后的关系

摘要
图/表
参考文献(23)
相关文章 (15)

全文: PDF (1169 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨肺鳞癌患者肿瘤组织中微小RNA（miRNA）-193a和miRNA-4286的表达水平与预后的关系，为肺癌预后评价提供新方向。方法选取2016年5月—2019年4月上海交通大学医学院附属新华医院确诊且临床资料完整的126例肺鳞癌患者为研究对象，通过实时荧光定量逆转录PCR（qRT-PCR）检测肺鳞癌组织和癌旁组织miRNA-193a和miRNA-4286的表达水平，分析肺鳞癌组织miRNA-193a和miRNA-4286与临床资料和预后的关系。结果肺鳞癌组织中miRNA-193a相对表达量低于癌旁组织，miRNA-4286相对表达量高于癌旁组织，差异均有统计学意义（均P ＜ 0.05）；肺鳞癌组织内miRNA-193a和miRNA-4286水平与年龄、性别、吸烟史和家族史无关联，差异无统计学意义（P ＞ 0.05），与肿瘤大小、TNM分期、淋巴结转移和复发情况有关联，差异均有统计学意义（均P ＜ 0.05）；肺鳞癌组织内miRNA-193a与分化程度无关联（P ＞ 0.05），而miRNA-4286与分化程度有关联（P ＜ 0.05）。肺鳞癌组织miRNA-193a低表达患者的中位生存期为36个月（95%CI：0.371~1.198），而高表达患者为54个月（95%CI：0.834~2.696），差异有统计学意义（P ＜ 0.05）；肺鳞癌组织miRNA-4286低表达患者的中位生存期为51个月（95%CI：0.962~2.660），而高表达患者为39个月（95%CI：0.376~1.039），差异有统计学意义（P ＜ 0.05）。结论肺鳞癌组织miRNA-193a和miRNA-4286表达水平与肿瘤大小、TNM分期、淋巴结转移和复发情况有关联，且与患者预后有关，miRNA-193a和miRNA-4286可能成为评价肺鳞癌患者预后的指标。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	毕锐王明松胡睿蒋连勇杨旭辉钟元

关键词 ：微小RNA-193a, 微小RNA-4286, 肺鳞癌, 预后

Abstract：Objective To explore the relationship between the expression levels of microRNA (miRNA)-193a and miRNA-4286 in the tumor tissues of squamous cell lung carcinoma patients and prognosis, so as to provide a new direction for the prognosis evaluation of lung cancer. Methods A total of 126 patients with squamous cell lung carcinoma diagnosed from May 2016 to April 2019 with complete clinical data in Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine were selected as research objects. The expression levels of miRNA-193a and miRNA-4286 in squamous cell lung carcinoma tissues and adjacent tissues were detected by real-time fluorescent quantitative reverse transcription PCR (qRT-PCR), and the relationship among miRNA-193a and miRNA-4286 in squamous cell lung carcinoma tissues and clinical data and prognosis were analyzed. Results The relative expression level of miRNA-193a in squamous cell lung carcinoma tissues was lower than that in adjacent tissues, and the relative expression level of miRNA-4286 was higher than that in adjacent tissues, with statistically significant differences (all P ＜ 0.05). The levels of miRNA-193a and miRNA-4286 in squamous cell lung carcinoma tissues were not correlated with age, sex, smoking history or family history, and the differences were not statistically significant (P ＞ 0.05). They were correlated with tumor size, TNM stage, lymph node metastasis and recurrence, and the differences were statistically significant (all P ＜ 0.05). miRNA-193a in squamous cell lung carcinoma tissues was not associated with the degree of differentiation (P ＞ 0.05), while miRNA-4286 was associated with the degree of differentiation (P ＜ 0.05). The median survival time of patients with low miRNA-193a expression in squamous cell lung carcinoma tissues was 36 months (95%CI: 0.371-1.198), while that of patients with high expression was 54 months (95%CI: 0.834-2.696), the difference was statistically significant (P ＜ 0.05). The median survival time of patients with low miRNA-4286 expression in squamous cell lung carcinoma tissues was 51 months (95%CI: 0.962-2.660), while that of patients with high expression was 39 months (95%CI: 0.376-1.039), the difference was statistically significant (P ＜ 0.05). Conclusion The expression levels of miRNA-193a and miRNA-4286 in squamous cell lung carcinoma are correlated with tumor size, TNM stage, lymph node metastasis and recurrence, and are related to the prognosis of patients. miRNA-193a and miRNA-4286 may be used as prognostic indicators for patients with squamous cell lung carcinoma.

Key words： microRNA-193a microRNA-4286 Squamous cell lung carcinoma Prognosis

基金资助:国家自然科学基金面上项目（81772459）。

通讯作者: 王明松（1972-），男，博士，主任医师；研究方向：心胸外科临床。

作者简介: 毕锐（1988-），男，硕士；研究方向：心胸外科临床。

引用本文:

毕锐王明松胡睿蒋连勇杨旭辉钟元. 肺鳞癌组织miRNA-193a及miRNA-4286水平与预后的关系[J]. 中国医药导报, 2020, 17(33): 9-12,60.
BI Rui WANG Mingsong HU Rui JIANG Lianyong YANG Xuhui ZHONG Yuan. Relationship between the levels of miRNA-193a and miRNA-4286 in tissues of squamous cell lung carcinoma and prognosis. 中国医药导报, 2020, 17(33): 9-12,60.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2020/V17/I33/9

[1] Mao Y，Yang D，He J，et al. Epidemiology of Lung Cancer [J]. Surg Oncol Clin N Am，2016，25（3）：439-445.
[2] 夏冰，江洪，王利民，等.肺癌30年临床研究进展[J].实用肿瘤杂志，2016，31（4）：296-300.
[3] 刘欢，李高峰.肺鳞癌的个体化治疗进展[J].现代肿瘤医学，2019，27（15）：2771-2775.
[4] 张小强，杜延玲.肺癌患者预后评估相关指标的研究进展[J].临床误诊误治，2017，30（12）：105-109.
[5] 金吉春，金星林.microRNA的概述及其研究[J].医学研究生学报，2013，26（10）：1109-1112.
[6] Lu TX，Rothenberg ME. MicroRNA [J]. J Allergy Clin Immunol，2018，141（4）：1202-1207.
[7] 贾友超，焦顺昌.微小RNA在肺癌精确诊断及靶向治疗中的应用[J].白求恩医学杂志，2016，14（1）：84-87.
[8] Rupaimoole R，Slack FJ. MicroRNA therapeutics：towards a new era for the management of cancer and other diseases [J]. Nat Rev Drug Discov，2017，16（3）：203-222.
[9] Goldstraw P，Crowley J，Chansky K，et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours [J]. J Thorac Oncol，2007，2（8）：706-714.
[10] 张建斌，闵伟伟，李鸿伟，等.非小细胞肺癌患者外周血中miRNA-4286表达的临床意义[J].浙江医学，2018， 40（6）：623-626.
[11] Krol J，Loedige I，Filipowicz W. The widespread regulation of microRNA biogenesis，function and decay [J]. Nat Rev Genet，2010，11（9）：597-610.
[12] Vishnoi A，Rani S. MiRNA Biogenesis and Regulation of Diseases：An Overview [J]. Methods Mol Biol，2017， 1509：1-10.
[13] Hejazi M，Baghbani E，Amini M，et al. MicroRNA-193a and taxol combination: A new strategy for treatment of colorectal cancer [J]. J Cell Biochem，2020，121(2)：1388-1399.
[14] 赵华，顾元忻，李栋立，等.微小RNA-4286在非小细胞肺癌组织的表达及临床意义[J].中华实验外科杂志，2019（9）：1540-1542.
[15] 于佳慧，祝旭东，李菁瑗，等.miRNA与心血管疾病关系的研究进展[J].解剖科学进展，2018，24（4）：420-423，427.
[16] Lin M，Zhang Z，Gao M，et al. MicroRNA-193a-3p suppresses the colorectal cancer cell proliferation and progression through downregulating the PLAU expression [J]. Cancer Manag Res，2019，12（11）：5353-5363.
[17] 杨鑫苗，张永强.miRNA调控实体肿瘤发生发展机制研究进展[J].现代肿瘤医学，2020，28（9）：1587-1589.
[18] Zhang M，Tian H，Li R，et al. MicroRNA-4286 promotes esophageal carcinoma development by targeting INPP4A to evoke the JAK2/STAT3 pathway activation [J]. Pharmazie，2018，73（6）：342-348.
[19] 郭红艳，高勇，张春晶，等.血清microRNA-4286表达与胃癌临床病理特征的关系及其临床意义[J].中国现代医学杂志，2019，29（10）：27-32.
[20] 谭晓刚，支修益.MicroRNA与非小细胞肺癌[J].首都医科大学学报，2015，36（4）：519-524.
[21] 霍红日，杨智勇，朱玲莉.miRNA-193a在肺腺癌患者体内的表达水平及意义[J].国际检验医学杂志，2017， 38（13）：1773-1775.
[22] Ling C，Wang X，Zhu J，et al. MicroRNA-4286 promotes cell proliferation，migration，and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer [J]. Cancer Med，2019，8（7）：3520-3531.
[23] Lin M，Duan B，Hu J，et al. Decreased expression of miR-193a-3p is associated with poor prognosis in colorectal cancer [J]. Oncol Lett，2017，14（1）：1061-1067.